These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30926633)

  • 21. Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
    Furuki H; Yamada T; Takahashi G; Iwai T; Koizumi M; Shinji S; Yokoyama Y; Takeda K; Taniai N; Uchida E
    Eur J Surg Oncol; 2018 Jul; 44(7):975-982. PubMed ID: 29452859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.
    Malapelle U; Pisapia P; Sgariglia R; Vigliar E; Biglietto M; Carlomagno C; Giuffrè G; Bellevicine C; Troncone G
    J Clin Pathol; 2016 Sep; 69(9):767-71. PubMed ID: 26797410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EphA3 promotes malignant transformation of colorectal epithelial cells by upregulating oncogenic pathways.
    Li M; Yang C; Liu X; Yuan L; Zhang F; Wang M; Miao D; Gu X; Jiang S; Cui B; Tong J; Yu Z
    Cancer Lett; 2016 Dec; 383(2):195-203. PubMed ID: 27721017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas.
    Rand V; Huang J; Stockwell T; Ferriera S; Buzko O; Levy S; Busam D; Li K; Edwards JB; Eberhart C; Murphy KM; Tsiamouri A; Beeson K; Simpson AJ; Venter JC; Riggins GJ; Strausberg RL
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14344-9. PubMed ID: 16186508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation-introduced dimerization of receptor tyrosine kinases: from protein structure aberrations to carcinogenesis.
    Hu H; Liu Y; Jiang T
    Tumour Biol; 2015 Mar; 36(3):1423-8. PubMed ID: 25750036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells.
    Song Q; Sun X; Guo H; Yu Q
    Oncotarget; 2017 Jan; 8(3):5003-5015. PubMed ID: 28002807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor tyrosine kinases: from biology to pathology.
    Choura M; Rebaï A
    J Recept Signal Transduct Res; 2011 Dec; 31(6):387-94. PubMed ID: 22040163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
    Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
    BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
    Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
    Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
    Makishima H; Sugimoto Y; Szpurka H; Clemente MJ; Ng KP; Muramatsu H; O'Keefe C; Saunthararajah Y; Maciejewski JP
    Leukemia; 2012 Jul; 26(7):1547-54. PubMed ID: 22246246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes.
    Willard MD; Lajiness ME; Wulur IH; Feng B; Swearingen ML; Uhlik MT; Kinzler KW; Velculescu VE; Sjöblom T; Markowitz SD; Powell SM; Vogelstein B; Barber TD
    Mol Cancer Res; 2012 Jun; 10(6):739-49. PubMed ID: 22516348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular evolution of the genes encoding receptor tyrosine kinase with immunoglobulinlike domains.
    Rousset D; Agnès F; Lachaume P; André C; Galibert F
    J Mol Evol; 1995 Oct; 41(4):421-9. PubMed ID: 7563129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell lines expressing recombinant transmembrane domain-activated receptor kinases as tools for drug discovery.
    Weber H; Müller D; Müller M; Ortiz A; Birkle M; Umber S; Ketterer C; Siedentopf O; Feger D; Totzke F; Kubbutat M; Schaechtele C; Ballmer-Hofer K; Ehlert JE; Graeser R
    J Biomol Screen; 2014 Dec; 19(10):1350-61. PubMed ID: 25260782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity.
    Patyna S; Laird AD; Mendel DB; O'farrell AM; Liang C; Guan H; Vojkovsky T; Vasile S; Wang X; Chen J; Grazzini M; Yang CY; Haznedar JO; Sukbuntherng J; Zhong WZ; Cherrington JM; Hu-Lowe D
    Mol Cancer Ther; 2006 Jul; 5(7):1774-82. PubMed ID: 16891463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic mutations of the ERBB4 kinase domain in human cancers.
    Soung YH; Lee JW; Kim SY; Wang YP; Jo KH; Moon SW; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
    Int J Cancer; 2006 Mar; 118(6):1426-9. PubMed ID: 16187281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
    Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Huh I; Park T; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Cancer; 2017 Sep; 123(18):3513-3523. PubMed ID: 28513830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing.
    Wu H; Zhang XY; Hu Z; Hou Q; Zhang H; Li Y; Li S; Yue J; Jiang Z; Weissman SM; Pan X; Ju BG; Wu S
    Oncogene; 2017 May; 36(20):2857-2867. PubMed ID: 27941887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice.
    Liu L; Yu XZ; Li TS; Song LX; Chen PL; Suo TL; Li YH; Wang SD; Chen Y; Ren YM; Zhang SP; Chang ZJ; Fu XY
    Cancer Res; 2004 May; 64(10):3491-9. PubMed ID: 15150103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.
    Nagahara H; Mimori K; Ohta M; Utsunomiya T; Inoue H; Barnard GF; Ohira M; Hirakawa K; Mori M
    Clin Cancer Res; 2005 Feb; 11(4):1368-71. PubMed ID: 15746034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine kinase receptors as attractive targets of cancer therapy.
    Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.